TY - JOUR T1 - Aerosolized Prostacyclins JF - Respiratory Care SP - 640 LP - 652 VL - 49 IS - 6 AU - Mark Siobal Y1 - 2004/06/01 UR - http://rc.rcjournal.com/content/49/6/640.abstract N2 - Two prostacyclins (prostaglandin E1 and prostaglandin I2) are potent vasodilators. Aerosolized prostacyclins reduce pulmonary artery pressure, improve right heart function, and increase arterial oxygenation by improving ventilation/perfusion matching. This report describes aerosolized prostacyclins and compares them to inhaled nitric oxide. I review the types of inhalable prostacyclins and their indications, evidence of efficacy, delivery, and adverse effects. ER -